LONDON (Reuters) - News that GlaxoSmithKline will have a new chief executive in 12 months has fueled speculation about a break-up of Britain's biggest drugmaker but outgoing boss Andrew Witty says this is wide of the mark.
http://ift.tt/xePdMM
from Reuters: Health News
via
animenewspro
Aucun commentaire:
Enregistrer un commentaire